For the latest COVID information Click Here.
Supporting safe practices for low-dose methotrexate: CATAG Position Statement on the use of low-dose methotrexate
AOA/ARA Position Statement on stem cell therapy
ARA Position Statement on the introduction of biosimilars for the treatment of rheumatic diseases
ARA Position Statement on the use of medicinal cannabis for musculoskeletal pain
ARA Recommendations on biological agents and small molecule medications for the treatment of rheumatic diseases - coming soon, currently being updated
ARA and Arthritis Australia Statement regarding the use of glucosamine for the treatment of Osteoarthritis